A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension

NCT07654140 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Uncontrolled Hypertension

Interventions

DRUG: SAL0140
DRUG: SAL0140
DRUG: SAL0140
DRUG: Placebo

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.